Education
About Us
Working with TipRanks
Follow Us
Avecho Biotechnology Limited (AU:AVE)
:AVE
AVE Stock Chart & Stats
<$0.01
$0.00(0.00%)
At close: 4:00 PM EST
<$0.01
$0.00(0.00%)
Day’s RangeN/A
52-Week Range― - ―
Previous CloseN/A
Volume188.16K
Average Volume (3M)N/A
Market Cap
$14.28M
Enterprise Value$6.63M
Total Cash (Recent Filing)$5.93M
Total Debt (Recent Filing)$57.12K
Price to Earnings (P/E)―
Beta1.81
Next Earnings
Sep 01, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding3,173,463,600
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio0.06
Price to Book (P/B)1.91
Price to Sales (P/S)5.51
P/FCF Ratio-1.57
Enterprise Value/Market Cap0.46
Enterprise Value/Revenue6.02
Enterprise Value/Gross Profit10.01
Enterprise Value/Ebitda-3.16
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Avecho Biotechnology Limited News
AVE FAQ
What was Avecho Biotechnology Limited’s price range in the past 12 months?
Currently, no data Available
What is Avecho Biotechnology Limited’s market cap?
Avecho Biotechnology Limited’s market cap is $14.28M.
When is Avecho Biotechnology Limited’s upcoming earnings report date?
Avecho Biotechnology Limited’s upcoming earnings report date is Sep 01, 2025 which is 50 days ago.
How were Avecho Biotechnology Limited’s earnings last quarter?
Avecho Biotechnology Limited released its earnings results on Feb 27, 2025. The company reported $0 earnings per share for the quarter, the consensus estimate of N/A by $0.
Is Avecho Biotechnology Limited overvalued?
According to Wall Street analysts Avecho Biotechnology Limited’s price is currently Overvalued.
Does Avecho Biotechnology Limited pay dividends?
Avecho Biotechnology Limited does not currently pay dividends.
What is Avecho Biotechnology Limited’s EPS estimate?
Avecho Biotechnology Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Avecho Biotechnology Limited have?
Avecho Biotechnology Limited has 3,173,463,600 shares outstanding.
What happened to Avecho Biotechnology Limited’s price movement after its last earnings report?
Avecho Biotechnology Limited reported an EPS of $0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Avecho Biotechnology Limited?
Currently, no hedge funds are holding shares in AU:AVE
Avecho Biotechnology Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:AVE Sentiment 89%
Sector Average 69%
Sector Average 69%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Fundamentals
Return on Equity
-143.71%
Trailing 12-Months
Asset Growth
22.64%
Trailing 12-Months
Company Description
Avecho Biotechnology Limited
Avecho Biotechnology Limited (AVE) is an Australian-based biotechnology company focused on the development and commercialization of innovative drug delivery systems. The company specializes in enhancing the delivery and effectiveness of pharmaceutical and consumer health products using its proprietary Targeted Penetration Matrix (TPM) technology. Avecho's core products include advanced drug formulations for improved absorption and bioavailability across various therapeutic areas, including dermatology, pain management, and animal health.
Living Cell Technologies
―
Immuron Limited
―
Noxopharm Ltd.
―
Chimeric Therapeutics Ltd.
―
Memphasys Ltd
―